Eliot Blatt (@eliotblatt) 's Twitter Profile
Eliot Blatt

@eliotblatt

Postdoctoral Researcher at UT Southwestern | PhD in Cancer Biology

ID: 1166057647428308994

calendar_today26-08-2019 18:39:57

15 Tweet

56 Takipçi

43 Takip Edilen

Eliot Blatt (@eliotblatt) 's Twitter Profile Photo

Our review on mechanisms of therapy resistance in breast and prostate cancers is now online. Go check it out! Ganesh Raj Ping Mu 🇺🇦 erc.bioscientifica.com/view/journals/…

David R. Liu (@davidrliu) 's Twitter Profile Photo

William Daniel et al. in NEJM report a dramatic decrease in #COVID19 incidence among fully vaccinated employees at UTSW Medical Center, and a large drop in overall #SARSCoV2 positivity rate after vaccinating a large fraction of their employees. 🧬 💉 😇 nejm.org/doi/full/10.10…

Julian Meeks (@meeksandmilds) 's Twitter Profile Photo

🚨 Preprint alert 🚨! biorxiv.org/content/10.110… This is a big one for the lab, the first since we moved to Del Monte Institute for Neuroscience in 2020! Hard to find happiness in a world filled w/such insanity ... but this is a source of 😄😀😃. This is the work of Kelsey Zuk, superstar. (1/N)

Oncogene Journal (@oncogenejournal) 's Twitter Profile Photo

From Ganesh Raj , Eliot Blatt & co-workers: Identification of the central role of #antioxidant programs in enzalutamide-resistant #ProstateCancer 🔬nature.com/articles/s4138…

Eliot Blatt (@eliotblatt) 's Twitter Profile Photo

If you're interested in how targeting redox homeostasis may provide therapeutic benefit to patients with therapy-resistant cancers, take a look at the article below! cancercommunity.nature.com/posts/targetin…

Eliot Blatt (@eliotblatt) 's Twitter Profile Photo

Thank you to Nature Reviews Urology for highlighting our recent publication on the metabolic alterations contributing to enzalutamide resistance! nature.com/articles/s4158…

Eliot Blatt (@eliotblatt) 's Twitter Profile Photo

I'm happy to share my first paper from the @RJDLab, a focus piece highlighting work from Papagiannakopoulos Lab and recent advancements in efforts to target glutamine metabolism in cancer. Glutamine antagonists may KEAP lung cancer in check | Science Advances science.org/doi/10.1126/sc…